These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37759223)

  • 1. Effect and mechanism of HMG-CoA reductase inhibitor on the improvement of elderly essential hypertension-induced vascular endothelial function impairment based on the JAK/STAT pathway.
    Yuan W; Fan H; Yang H; Tang L; Liu Z; Ouyang F; Luo W; Yan Y
    Diagn Pathol; 2023 Sep; 18(1):108. PubMed ID: 37759223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
    Wassmann S; Laufs U; Bäumer AT; Müller K; Ahlbory K; Linz W; Itter G; Rösen R; Böhm M; Nickenig G
    Hypertension; 2001 Jun; 37(6):1450-7. PubMed ID: 11408394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase.
    Suh JW; Choi DJ; Chang HJ; Cho YS; Youn TJ; Chae IH; Kim KI; Kim CH; Kim HS; Oh BH; Park YB
    J Korean Med Sci; 2010 Jan; 25(1):16-23. PubMed ID: 20052342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats.
    Okamura T; Tawa M; Geddawy A; Shimosato T; Iwasaki H; Shintaku H; Yoshida Y; Masada M; Shinozaki K; Imamura T
    J Pharmacol Sci; 2014; 124(1):76-85. PubMed ID: 24389820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific effects of atorvastatin on 3-hydroxy-3-methylglutarylcoenzyme A reductase expression and activity in spontaneously hypertensive rats.
    Chen GP; Yao L; Lu X; Li L; Hu SJ
    Acta Pharmacol Sin; 2008 Oct; 29(10):1181-6. PubMed ID: 18817622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG-CoA reductase inhibitor rosuvastatin improves abnormal brain electrical activity via mechanisms involving eNOS.
    Seker FB; Kilic U; Caglayan B; Ethemoglu MS; Caglayan AB; Ekimci N; Demirci S; Dogan A; Oztezcan S; Sahin F; Yilmaz B; Kilic E
    Neuroscience; 2015 Jan; 284():349-359. PubMed ID: 25453767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension.
    Satoh M; Satoh A
    J Pharm Pharm Sci; 2009 Feb; 11(2):118s-130s. PubMed ID: 19203474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.
    Rosenson RS
    Am J Cardiovasc Drugs; 2001; 1(6):411-20. PubMed ID: 14728000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
    Wagner AH; Gebauer M; Güldenzoph B; Hecker M
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1784-9. PubMed ID: 12426205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
    Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y
    Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin attenuates hypertrophic responses induced by cardiotrophin-1 via JAK-STAT pathway in cultured cardiomyocytes.
    Wu L; Zhao L; Zheng Q; Shang F; Wang X; Wang L; Lang B
    Mol Cell Biochem; 2006 Mar; 284(1-2):65-71. PubMed ID: 16534557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
    Rakotoniaina Z; Guerard P; Lirussi F; Goirand F; Rochette L; Dumas M; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):195-206. PubMed ID: 17102939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells.
    Morikawa S; Umetani M; Nakagawa S; Yamazaki H; Suganami H; Inoue K; Kitahara M; Hamakubo T; Kodama T; Saito Y
    J Atheroscler Thromb; 2000; 7(3):138-44. PubMed ID: 11480454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combined statin and ACE inhibitor therapy on endothelial function and blood pressure in essential hypertension - a randomised double-blind, placebo controlled crossover study.
    Ruszkowski P; Masajtis-Zagajewska A; Nowicki M
    J Renin Angiotensin Aldosterone Syst; 2019; 20(3):1470320319868890. PubMed ID: 31486700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated enzyme inhibition assay method for the determination of atorvastatin-derived HMG-CoA reductase inhibitors in human plasma using radioactivity detection.
    Valesky RJ; Liu L; Musson DG; Zhao JJ
    J Pharmacol Toxicol Methods; 2008; 57(1):61-9. PubMed ID: 17651990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
    Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
    Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase.
    Laufs U; Fata VL; Liao JK
    J Biol Chem; 1997 Dec; 272(50):31725-9. PubMed ID: 9395516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium ionophore treatment impairs the sterol-mediated suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, 3-hydroxy-3-methylglutaryl-coenzyme A synthase, and farnesyl diphosphate synthetase.
    Wilkin DJ; Edwards PA
    J Biol Chem; 1992 Feb; 267(4):2831-6. PubMed ID: 1346397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway.
    Al-Rasheed NM; Al-Oteibi MM; Al-Manee RZ; Al-Shareef SA; Al-Rasheed NM; Hasan IH; Mohamad RA; Mahmoud AM
    Drug Des Devel Ther; 2015; 9():3217-29. PubMed ID: 26150695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension.
    Zhou MS; Tian R; Jaimes EA; Raij L
    Am J Hypertens; 2014 Jun; 27(6):873-80. PubMed ID: 24413709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.